Jérôme Berge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jérôme Berge has a total of 408 co-authors. Here are the top co-authors by number of shared publications:
- Gaultier Marnat
Department of Neuroradiology, Bordeaux University Hospital, Bordeaux, France
12 shared publications Hubert Desal
Department of Neuroradiology, Nantes University Hospital, Nantes, France
5 shared publications- Benjamin Gory
Department of Diagnostic and Therapeutic Neuroradiology, CHRU-Nancy, Nancy, France
4 shared publications - Florent Gariel
Departments of Neuroradiology (F.G., G.M.)
4 shared publications Igor Sibon
Department of Neurology, Martinique University Hospital, Fort-de-France, France
4 shared publications- Vincent Dousset
From the Institut de Bio-imagerie IBIO (F.M., T.T., V.D.), Université Bordeaux, Bordeaux, France
4 shared publications
Latest Publications
- 22 June 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 152, 112160
Impact of a newly opened mechanical thrombectomy center on stroke management: volume, delays, and clinical outcomes
- 22 June 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 152, 112160
Impact of a newly opened mechanical thrombectomy center on stroke management: volume, delays, and clinical outcomes
- 23 May 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- p. ajnr.A9425
Improved safety of intracranial aneurysm coiling with OPTIMA™: Results of the INSTANT study
Coiling remains a widely used, first-line endovascular treatment for intracranial aneurysms. However, recent large-scale evaluations are limited since the ARETA study, which assessed the safety and efficacy of aneurysm coiling in patients treated between 2013 - 2015. A detailed analysis of the INSTANT study is presented, which provides recent data on endovascular treatment of intracranial aneurysms with the OPTIMA™ coil system (Balt). INSTANT is a European, non-interventional, prospective study that assessed patients with ruptured, unruptured, or recanalized aneurysms treated with OPTIMA™. The primary endpoint was the morbi-mortality of patients treated with OPTIMA™ at 30 days, with an additional assessment at 12 months as a secondary endpoint. From April 2019 to September 2022, 294 patients (56.3±12.0 years, 186 women [63.3%]) were enrolled in 18 European centers. Aneurysms were acutely ruptured in 45.2% of cases (N=133/294) and unruptured/recanalized in 54.8% (N=161/294). The overall mortality at 30 days was 0.0% in patients with unruptured aneurysms and 3.0% (N=4/133, [95% CI:0.1-5.9]) in those with ruptured aneurysms, which were all related to SAH and its complications. Overall, morbidity at 30 days was 1.2% (N=2/161, [95% CI:0.0-3.0]) in patients with unruptured aneurysms and 21.1% (N=28/133, [95% CI:14.1-28.0]) in patients with ruptured aneurysms. No deaths or adverse events resulting in morbidity were related to OPTIMA™ or the procedure (0.0%). In the INSTANT study, treatment of intracranial aneurysms with the OPTIMA™ coil system showed low morbidity and mortality at 30 days and 12 months, unrelated to the device or procedure.
- 23 May 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- p. ajnr.A9425
Improved safety of intracranial aneurysm coiling with OPTIMA™: Results of the INSTANT study
Coiling remains a widely used, first-line endovascular treatment for intracranial aneurysms. However, recent large-scale evaluations are limited since the ARETA study, which assessed the safety and efficacy of aneurysm coiling in patients treated between 2013 - 2015. A detailed analysis of the INSTANT study is presented, which provides recent data on endovascular treatment of intracranial aneurysms with the OPTIMA™ coil system (Balt). INSTANT is a European, non-interventional, prospective study that assessed patients with ruptured, unruptured, or recanalized aneurysms treated with OPTIMA™. The primary endpoint was the morbi-mortality of patients treated with OPTIMA™ at 30 days, with an additional assessment at 12 months as a secondary endpoint. From April 2019 to September 2022, 294 patients (56.3±12.0 years, 186 women [63.3%]) were enrolled in 18 European centers. Aneurysms were acutely ruptured in 45.2% of cases (N=133/294) and unruptured/recanalized in 54.8% (N=161/294). The overall mortality at 30 days was 0.0% in patients with unruptured aneurysms and 3.0% (N=4/133, [95% CI:0.1-5.9]) in those with ruptured aneurysms, which were all related to SAH and its complications. Overall, morbidity at 30 days was 1.2% (N=2/161, [95% CI:0.0-3.0]) in patients with unruptured aneurysms and 21.1% (N=28/133, [95% CI:14.1-28.0]) in patients with ruptured aneurysms. No deaths or adverse events resulting in morbidity were related to OPTIMA™ or the procedure (0.0%). In the INSTANT study, treatment of intracranial aneurysms with the OPTIMA™ coil system showed low morbidity and mortality at 30 days and 12 months, unrelated to the device or procedure.
- 21 July 2025
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 52 (5) , 101373
Single-stent strategy for a dissected carotid loop in acute tandem occlusion: Technical considerations
- 21 July 2025
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 52 (5) , 101373
Single-stent strategy for a dissected carotid loop in acute tandem occlusion: Technical considerations
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 312 (2) , e233041
Assessment of Thrombectomy versus Combined Thrombolysis and Thrombectomy in Patients with Acute Ischemic Stroke and Medium Vessel Occlusion
This international multicenter study found that adjunctive intravenous thrombolysis may not provide benefit to mechanical thrombectomy in patients with acute ischemic stroke caused by distal and medium vessel occlusion.
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 312 (2) , e233041
Assessment of Thrombectomy versus Combined Thrombolysis and Thrombectomy in Patients with Acute Ischemic Stroke and Medium Vessel Occlusion
This international multicenter study found that adjunctive intravenous thrombolysis may not provide benefit to mechanical thrombectomy in patients with acute ischemic stroke caused by distal and medium vessel occlusion.
- Open Access
- 1 March 2024
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 9 (1) , 114-123
First pass effect as an independent predictor of functional outcomes in medium vessel occlusions: An analysis of an international multicenter study
Introduction: First pass effect (FPE), achievement of complete recanalization (mTICI 2c/3) with a single pass, is a significant predictor of favorable outcomes for endovascular treatment (EVT) in large vessel occlusion stroke (LVO). However, data concerning the impact on functional outcomes and predictors of FPE in medium vessel occlusions (MeVO) are scarce. Patients and Methods: We conducted an international retrospective study on MeVO cases. Multivariable logistic modeling was used to establish independent predictors of FPE. Clinical and safety outcomes were compared between the two study groups (FPE vs non-FPE) using logistic regression models. Good outcome was defined as modified Rankin Scale 0–2 at 3 months. Results: Eight hundred thirty-six patients with a final mTICI ⩾ 2b were included in this analysis. FPE was observed in 302 patients (36.1%). In multivariable analysis, hypertension (aOR 1.55, 95% CI 1.10–2.20) and lower baseline NIHSS score (aOR 0.95, 95% CI 0.93–0.97) were independently associated with an FPE. Good outcomes were more common in the FPE versus non-FPE group (72.8% vs 52.8%), and FPE was independently associated with favorable outcome (aOR 2.20, 95% CI 1.59–3.05). 90-day mortality and intracranial hemorrhage (ICH) were significantly lower in the FPE group, 0.43 (95% CI, 0.25–0.72) and 0.55 (95% CI, 0.39–0.77), respectively. Conclusion: Over 2/3 of patients with MeVOs and FPE in our cohort had a favorable outcome at 90 days. FPE is independently associated with favorable outcomes, it may reduce the risk of any intracranial hemorrhage, and 3-month mortality.
- 1 March 2024
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 9 (1) , 114-123
Open AccessFirst pass effect as an independent predictor of functional outcomes in medium vessel occlusions: An analysis of an international multicenter study
Introduction: First pass effect (FPE), achievement of complete recanalization (mTICI 2c/3) with a single pass, is a significant predictor of favorable outcomes for endovascular treatment (EVT) in large vessel occlusion stroke (LVO). However, data concerning the impact on functional outcomes and predictors of FPE in medium vessel occlusions (MeVO) are scarce. Patients and Methods: We conducted an international retrospective study on MeVO cases. Multivariable logistic modeling was used to establish independent predictors of FPE. Clinical and safety outcomes were compared between the two study groups (FPE vs non-FPE) using logistic regression models. Good outcome was defined as modified Rankin Scale 0–2 at 3 months. Results: Eight hundred thirty-six patients with a final mTICI ⩾ 2b were included in this analysis. FPE was observed in 302 patients (36.1%). In multivariable analysis, hypertension (aOR 1.55, 95% CI 1.10–2.20) and lower baseline NIHSS score (aOR 0.95, 95% CI 0.93–0.97) were independently associated with an FPE. Good outcomes were more common in the FPE versus non-FPE group (72.8% vs 52.8%), and FPE was independently associated with favorable outcome (aOR 2.20, 95% CI 1.59–3.05). 90-day mortality and intracranial hemorrhage (ICH) were significantly lower in the FPE group, 0.43 (95% CI, 0.25–0.72) and 0.55 (95% CI, 0.39–0.77), respectively. Conclusion: Over 2/3 of patients with MeVOs and FPE in our cohort had a favorable outcome at 90 days. FPE is independently associated with favorable outcomes, it may reduce the risk of any intracranial hemorrhage, and 3-month mortality.
- 13 January 2023
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (3) , 346-351
Ticagrelor versus clopidogrel dual antiplatelet therapy for unruptured intracranial aneurysms treated with flowdiverter
- 13 January 2023
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (3) , 346-351
Ticagrelor versus clopidogrel dual antiplatelet therapy for unruptured intracranial aneurysms treated with flowdiverter
- 20 December 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (4) , 444-448
Dual-layer carotid stenting for symptomatic carotid web: Results from the Caroweb study
- 20 December 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (4) , 444-448
Dual-layer carotid stenting for symptomatic carotid web: Results from the Caroweb study
- 25 March 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 49 (2) , 153-156
A new legal framework for Interventional Neuroradiology in France: optimizing access to mechanical thrombectomy
- 25 March 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 49 (2) , 153-156
A new legal framework for Interventional Neuroradiology in France: optimizing access to mechanical thrombectomy
- 25 March 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 49 (2) , 104-107
Réforme des autorisations : un nouveau cadre juridique pour la NRI Française
- 25 March 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 49 (2) , 104-107
Réforme des autorisations : un nouveau cadre juridique pour la NRI Française